| Uterine Carcinosarcoma studied in …STUDIED_INderived34 of 34show fewer |
|---|
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ALIAS · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156268Phase 2 · completed A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma · condition mapped ALIAS · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694262Phase 2 · completed The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05229601Phase 1 · terminated A Study of HFB301001 in Adult Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped ALIAS · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ALIAS · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Cervical Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015129Phase 2 · completed A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer · condition mapped ALIAS · 34 trials mapped (9 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01367301NA · terminated Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954174Phase 3 · unknown Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03902379NA · withdrawn Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168232Phase 2 · completed Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247571Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025506Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075400Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114218Phase 2 · completed Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061606Phase 2 · terminated Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390234Phase 2 · completed Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238121Phase 2 · completed Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ONTOLOGY_EXACT · 34 trials mapped (9 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |